ストックスクリーナーアプリを入手
10.09
0.20%
0.02
アフターアワーズ：
10.09
前日終値:
$10.07
開ける：
$10.04
24時間の取引高:
394.07K
Relative Volume:
1.23
時価総額：
$576.56M
収益：
-
当期純損益:
$-83.74M
株価収益率:
-6.2671
EPS:
-1.61
ネットキャッシュフロー:
$-64.98M
1週間 パフォーマンス:
-7.09%
1か月 パフォーマンス:
+27.40%
6か月 パフォーマンス:
-37.37%
1年 パフォーマンス:
-43.19%
1日の値動き範囲:
$9.84
$10.73
1週間の範囲:
$8.80
$10.99
52週間の値動き範囲:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
TYRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.09 | 576.56M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-07 | 開始されました | UBS | Buy |
| 2024-10-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-08-15 | 開始されました | Piper Sandler | Overweight |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-06-30 | 開始されました | Wedbush | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2021-10-11 | 開始されました | BofA Securities | Buy |
| 2021-10-11 | 開始されました | Cowen | Outperform |
| 2021-10-11 | 開始されました | Jefferies | Buy |
すべてを表示
Tyra Biosciences Inc (TYRA) 最新ニュース
What Will Tyra Biosciences Inc (NASDAQ: TYRA) Be Like In 2025 - Stocksregister
Tyra Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
One Tyra Biosciences Insider Raised Stake By 284% In Previous Year - Yahoo Finance
Barclays PLC Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (NASDAQ:TYRA) and Encourages Investors to Contact the Firm for Additional Information - ACCESS Newswire
Tyra Biosciences (TYRA) Secures Financial Stability for Oncology Advancements | TYRA Stock News - GuruFocus
Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights - Yahoo Finance
Analytical Lens: Exploring Tyra Biosciences Inc (TYRA)’s Financial Story Through Ratios - DWinneX
54,783 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Raymond James Financial Inc. - Defense World
29,100 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Renaissance Technologies LLC - Defense World
Tyra Biosciences (TYRA) to Release Earnings on Thursday - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co. - Defense World
Russell Investments Group Ltd. Acquires 10,447 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Geode Capital Management LLC Has $7.20 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences Inc [TYRA] Records 50-Day SMA of $10.39 - knoxdaily.com
Should investors be concerned about Tyra Biosciences Inc (TYRA)? - uspostnews.com
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.83 Average PT from Brokerages - Defense World
(TYRA) Investment Analysis and Advice - news.stocktradersdaily.com
Vanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Has $1.32 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
American Century Companies Inc. Sells 20,857 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
KLP Kapitalforvaltning AS Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - ACCESS Newswire
Advanced Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com
Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
HC Wainwright Predicts Reduced Earnings for Tyra Biosciences - Defense World
Tyra Biosciences stock hits 52-week low at $8.14 - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $8.14 By Investing.com - Investing.com South Africa
(TYRA) Technical Data - news.stocktradersdaily.com
HC Wainwright Reiterates “Buy” Rating for Tyra Biosciences (NASDAQ:TYRA) - The AM Reporter
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $30 target on Tyra Biosciences stock By Investing.com - Investing.com Canada
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Swiss National Bank - Defense World
What is Wedbush’s Estimate for TYRA FY2029 Earnings? - Defense World
Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights - Citizen Tribune
Wedbush Reiterates “Outperform” Rating for Tyra Biosciences (NASDAQ:TYRA) - Defense World
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth - Yahoo Finance
Charles Schwab Investment Management Inc. Trims Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Tyra Biosciences Advances Precision Medicine Pipeline - TipRanks
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Bank of New York Mellon Corp - Defense World
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges By Investing.com - Investing.com South Africa
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
Victory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthc - GuruFocus.com
US Bancorp DE Purchases Shares of 3,612 Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India
Tyra Biosciences Inc (TYRA) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):